Financial Highlights

（As of September 2024）

Financial Highlights（consolidated）

Net sales / Operating profit / Rate of operating profit to net sales

Profit attributable to owners of parent

Total net assets / Total assets / Equity-to-asset ratio

Pharmaceutical business net sales / R&D expenses / Ratio of R&D expenses to net sales

Financial Highlights（non-consolidated）

Net sales / Operating profit / Rate of operating profit to net sales

Profit attributable to owners of parent

Rating information

Rating Agency:: R&I

Rating:: A-

Date of rating:: 2024/09/19